AN-01 (Link Health Group)

N/A

Report date: 2024/11/21 15:14:13
NME

Base Information

Drug NameAN-01 (Link Health Group)
Drug Alias NameAN-01
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLink Health Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLink Health Group
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A